Raia Drogasil (OTCMKTS:RADLY) Stock Price Up 30% – Here’s Why

Raia Drogasil S.A. (OTCMKTS:RADLY)’s stock price traded up 30% on Monday. The company traded as high as $4.3541 and last traded at $4.35. 68,740 shares were traded during mid-day trading, a decline of 21% from the average daily volume of 86,665 shares. The stock had previously closed at $3.3450.

Raia Drogasil Stock Up 0.7%

The company has a market capitalization of $5.51 billion and a price-to-earnings ratio of 83.75. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99. The firm’s 50 day simple moving average is $3.69 and its 200-day simple moving average is $3.88.

Raia Drogasil (OTCMKTS:RADLY) last released its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The company had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.32 billion. Raia Drogasil had a net margin of 2.97% and a return on equity of 18.20%. On average, sell-side analysts anticipate that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.

About Raia Drogasil

Raia Drogasil SA, known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise.

The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products.